SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Endovascular aneurysm sealing for the treatment of ruptured abdominal aortic aneurysms.

de Bruin, JL; Brownrigg, JR; Karthikesalingam, A; Patterson, BO; Holt, PJ; Hinchliffe, RJ; Morgan, RA; Loftus, IM; Thompson, MM (2015) Endovascular aneurysm sealing for the treatment of ruptured abdominal aortic aneurysms. Journal of Endovascular Therapy, 22 (3). pp. 283-287. ISSN 1545-1550 https://doi.org/10.1177/1526602815582529
SGUL Authors: Holt, Peter James Edward Thompson, Matthew Merfyn

[img]
Preview
["document_typename_cannot open `/data/SGUL/sgul/eprints3/archives/sgul/documents/disk0/00/10/74/17/01/Endovascular' (No such file or directory) cannot open `aneurysm' (No such file or directory) cannot open `sealing' (No such file or directory) cannot open `for' (No such fi" not defined] Published Version
Available under License Creative Commons Attribution Non-commercial.

Download (637kB) | Preview

Abstract

PURPOSE: To assess the feasibility and report preliminary results of ruptured abdominal aortic aneurysm (rAAA) repair with endovascular aneurysm sealing (EVAS), a novel therapeutic alternative whose feasibility has not been established in rAAAs due to the unknown effects of the rupture site on the ability to achieve sealing. CASE REPORT: Between December 2013 and April 2014, 5 patients (median age 71 years, range 57-90; 3 men) with rAAAs were treated with the Nellix EVAS system at a single institution. Median aneurysm diameter was 70 mm (range 67-91). Aneurysm morphology in 4 of the 5 patients was noncompliant with instructions for use (IFU) for both EVAS and standard stent-grafts; the remaining patient was outside the IFU for standard stent-grafts but treated with EVAS under standard IFU for the Nellix system. Median Hardman index was 2 (range 0-3). Two patients died of multiorgan failure after re-laparotomy and intraoperative cardiac arrest, respectively. Among survivors, all devices were patent with no signs of endoleak or failed aneurysm sac sealing at 6 months (median follow-up 9.2 months). CONCLUSION: EVAS for the management of infrarenal rAAAs appears feasible. The use of EVAS in emergency repairs may broaden the selection criteria of the current endovascular strategy to include patients with more complex aneurysm morphology.

Item Type: Article
Additional Information: © The Author (s) 2015. This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).
Keywords: abdominal aortic aneurysm, aneurysm sac, complications, endobag, endovascular aneurysm sealing, mortality, ruptured aneurysm, stent-graft, abdominal aortic aneurysm, ruptured aneurysm, endovascular aneurysm sealing, stent-graft, endobag, complications, mortality, aneurysm sac, Cardiovascular System & Hematology, 1103 Clinical Sciences
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Academic Structure > Molecular and Clinical Sciences Research Institute (MCS) > Vascular & Cardiac Surgery (INCCVC)
Journal or Publication Title: Journal of Endovascular Therapy
ISSN: 1545-1550
Language: eng
Dates:
DateEvent
1 June 2015Published
Publisher License: Creative Commons: Attribution-Noncommercial 3.0
Projects:
Project IDFunderFunder ID
NIHR -CS-011-008National Institute for Health Researchhttp://dx.doi.org/10.13039/501100000272
PubMed ID: 25904491
Web of Science ID: WOS:000354868700001
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/107417
Publisher's version: https://doi.org/10.1177/1526602815582529

Actions (login required)

Edit Item Edit Item